Unravelling the unseen metabolic changes in patients with malignant hyperthermia

Can J Anaesth. 2021 Jun;68(6):751-754. doi: 10.1007/s12630-020-01896-x. Epub 2021 Feb 2.

Authors

Vikas Kaura¹, Leon Chang¹, Paul D Allen²

Affiliations

¹ Leeds Institute of Medical Research at St James's, Leeds, UK.
² Leeds Institute of Medical Research at St James's, Leeds, UK. P.D.Allen@leeds.ac.uk.

PMID: 33532996
DOI: 10.1007/s12630-020-01896-x

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Hyperthermia*
Malignant Hyperthermia* / etiology
Metabolomics
Muscle, Skeletal
Ryanodine Receptor Calcium Release Channel

Substances

Ryanodine Receptor Calcium Release Channel

Grants and funding

R01 AR068897/AR/NIAMS NIH HHS/United States